deoxoflobufen

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Namedeoxoflobufen

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLeukotriene B4 synthesis inhibitorsImmunomodulators

TargetsUpdating

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechia

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIvax Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesIvax Corp

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A